Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 970 Records) |
| Query Trace: Lung Neoplasms and KRAS[original query] |
|---|
| Returning from the afterlife? Sotorasib treatment for advanced KRAS mutant lung cancer: A case report. World journal of clinical cases 2024 9 12 (25): 5805-5813. Ming-Xing Wang, Pei Zhu, Yue Shi, Qing-Ming Sun, Wan-Hui Do |
| Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy. Journal of cancer research and clinical oncology 2024 9 150 (9): 413. Guomin Gu, Chunling Liu, Xiaodan Zhu, Yan Yang, Shuming Song, Yan Zhao, Gang S |
| Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
| Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 9 . Ping-Chih Hsu, John Wen-Cheng Chang, Li-Chung Chiu, Cheng-Ta Yang, Scott Chih-Hsi Kuo, Yueh-Fu Fang, Chiao-En |
| The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer. OncoTargets and therapy 2024 9 17 755-763. YuXuan Zhang, Yuhong Shen, Jiayuan Wu, Jun Zhang, Chenxi Cao, Juanfen Mo, Yi B |
| Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer. Cancer research communications 2024 8 . Daniel R Principe, Mary M Pasquinelli, Ryan H Nguyen, Hidayatullah G Munshi, Alicia Hulbert, Alexandre F Aissa, Frank Weinbe |
| Ancestry-, Sex-, and Age-Based Differences of Gene Alterations in NSCLC: From the Real-World Data of Cancer Genomic Profiling Tests. Journal of the National Comprehensive Cancer Network : JNCCN 2024 8 1-10. Keita Miura, Takehito Shukuya, Ray Greenstein, Ben Kaplan, Heather Wakelee, Kana Kurokawa, Kazuyuki Furuta, Shunsuke Kato, Junghee Suh, Smruthy Sivakumar, Ethan S Sokol, David P Carbone, Kazuhisa Takahas |
| Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer. JCO precision oncology 2024 8 8 e2300520. Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C Yin, Junli Zhang, Yang Shao, Chengming Sun, Renhua G |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy. Lung cancer (Amsterdam, Netherlands) 2024 8 195 107927. Julia Naso, Aakash Desai, Caleb J Smith, Yash P Ashara, Stephen Yip, Ying-Chun |
| Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis. Molecular diagnosis & therapy 2024 8 . Cheng Chen, Michael P Douglas, Meera V Ragavan, Kathryn A Phillips, Jeroen P Jans |
| TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Frontiers in oncology 2024 8 14 1357583. Armin Frille, Myriam Boeschen, Hubert Wirtz, Mathias Stiller, Hendrik Bläker, Maximilian von Laffe |
| Pulmonary adenocarcinoma with enteric differentiation (PAED) without TTF-1 expression is a very rare subtype with limited treatment options and poor prognosis. Oncology 2024 8 . Franziska Maria Kraus, Alexander Traut, Georg Nilius, Jan Volmerig, Andreas Koziorowski, Imke Stöver, Florian Grabellus, Michael Stahl, Daniel C Christo |
| Unusual Synchronous Multiple Primary Early-Stage Lung Adenocarcinoma with Concomitant MET Exon 14 Skipping, PIK3CA and KRAS Mutations: A Case Report. Case reports in oncology 2024 8 17 (1): 874-881. Yongjing Zhang, Qiqi G |
| RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clinical lung cancer 2024 8 . Amanda Reyes, Michelle Afkhami, Erminia Massarelli, Jeremy Fricke, Isa Mambetsariev, Xiaochen Li, Giovanny Velasquez, Ravi Salg |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| PARP4 interacts with hnRNPM to regulate splicing during lung cancer progression. Genome medicine 2024 7 16 (1): 91. Yi Fei Lee, Cheryl Zi Jin Phua, Ju Yuan, Bin Zhang, May Yin Lee, Srinivasaraghavan Kannan, Yui Hei Jasper Chiu, Casslynn Wei Qian Koh, Choon Kong Yap, Edwin Kok Hao Lim, Jianbin Chen, Yuhua Lim, Jane Jia Hui Lee, Anders Jacobsen Skanderup, Zhenxun Wang, Weiwei Zhai, Nguan Soon Tan, Chandra S Verma, Yvonne Tay, Daniel Shao Weng Tan, Wai Leong T |
| Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC. European journal of cancer (Oxford, England : 1990) 2024 7 208 114204. Maximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, Enric Carcereny, Christophe Dooms, Se-Hoon Lee, Eva Morocz, Terufumi Kato, Tudor-Eliade Ciuleanu, Grace K Dy, Barbara Parente, Kenneth J O'Byrne, Quincy S Chu, Gilberto De Castro Junior, Nicolas Girard, Wendy Snyder, Qui Tran, William Kormany, Brett Houk, Bhakti Mehta, Alessandra Curioni-Fonteced |
| KRAS and BRAF genetic alterations in lung cancer: A case - control study. Journal of cancer research and therapeutics 2024 7 20 (3): 782-787. Humaira Aziz Sawal, Syeda Ibtesam Shah, Saima Shakil Malik, Sarmad Mehmood, Mehreen Baig, Ehtsham Rasool, Nosheen Maso |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| Predictive [F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer. Academic radiology 2024 7 . Ricarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, Vanessa Murad, Seyed Ali Mirshahvalad, Lisa Avery, Claudia Ortega, Ur Metser, Andrew Hope, Jonathan Yeung, Micheal McInnis, Patrick Veit-Haiba |
| Circulating tumor DNA dynamics reveal KRAS G12C mutation heterogeneity and response to treatment with the KRAS G12C inhibitor divarasib in solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Yoonha Choi, Neekesh V Dharia, Tomi Jun, Julie Chang, Stephanie Royer-Joo, Kenneth K Yau, Zoe June Assaf, Junko Aimi, Smruthy Sivakumar, Meagan Montesion, Adrian Sacher, Patricia LoRusso, Jayesh Desai, Jennifer L Schutzman, Zhen S |
| Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice. Pathology 2024 6 . Simon Garinet, Audrey Lupo, Thomas Denize, Romain Loyaux, Sarah Timsit, Benoit Gazeau, Elizabeth Fabre, Zineb Maaradji, Laure Gibault, Etienne Giroux-Leprieur, Boris Duchemann, Isabelle Monnet, Stéphane Jouveshomme, Mihaela Aldea, Benjamin Besse, Françoise Le Pimpec-Barthes, Karen Leroy, Marie Wislez, Hélène Blo |
| Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. The oncologist 2024 6 . Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Murilo Bonatelli, Iara Santana, Eduardo Caetano Albino da Silva, Gustavo Ramos Teixeira, Beatriz Garbe Zaniolo, Josiane Mourão Dias, Flávio Augusto Ferreira da Silva, Carlos Eduardo Baston Silva, Marcela Gondim Borges Guimarães, Camila Pinto Barone, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, José Elias Miziara, Pedro De Marchi, Miguel A Molina-Vila, Letícia Ferro Leal, Rui Manuel Re |
| Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco. The Pan African medical journal 2024 6 47 116. Ouafaa Morjani, Nouhad Benkirane, Hassan Errihani, El Mostafa Elfahime, Hamid Lakhia |
| Additional impact of genetic ancestry over self-reported race/ethnicity to prevalence of KRAS mutations and allele-specific subtypes in non-small cell lung cancer. HGG advances 2024 6 100320. Xinan Wang, Kangcheng Hou, Biagio Ricciuti, Joao V Alessi, Xihao Li, Federica Pecci, Rounak Dey, Jia Luo, Mark M Awad, Alexander Gusev, Xihong Lin, Bruce E Johnson, David C Christia |
| Assessing the prognostic value of KRAS mutation combined with tumor size in stage I-II non-small cell lung cancer: a retrospective analysis. Frontiers in oncology 2024 6 14 1396285. Ella A Eklund, Ali Mourad, Clotilde Wiel, Sama I Sayin, Henrik Fagman, Andreas Hallqvist, Volkan I Say |
| The mutagenic forces shaping the genomic landscape of lung cancer in never smokers. medRxiv : the preprint server for health sciences 2024 5 . Marcos Díaz-Gay, Tongwu Zhang, Phuc H Hoang, Azhar Khandekar, Wei Zhao, Christopher D Steele, Burçak Otlu, Shuvro P Nandi, Raviteja Vangara, Erik N Bergstrom, Mariya Kazachkova, Oriol Pich, Charles Swanton, Chao Agnes Hsiung, I-Shou Chang, Maria Pik Wong, Kin Chung Leung, Jian Sang, John McElderry, Lixing Yang, Martin A Nowak, Jianxin Shi, Nathaniel Rothman, David C Wedge, Robert Homer, Soo-Ryum Yang, Qing Lan, Bin Zhu, Stephen J Chanock, Ludmil B Alexandrov, Maria Teresa Lan |
| Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data. Therapeutic advances in medical oncology 2024 10 16 17588359241279715. Shuting Zhan, Jianfu Li, Bo Cheng, Caichen Li, Yi Feng, Lei Fan, Shan Xiong, Wenchuang Zeng, Qi Cai, Yang Xiang, Huiting Wang, Chunyan Li, Peiling Chen, Xin Zheng, Wenhai Fu, Zhexue Hao, Jianxing He, Wenhua Lia |
| Potent covalent irreversible inhibitor of KRAS G12C IBI351 in patients with advanced solid tumors: First-in-human phase I study. European journal of cancer (Oxford, England : 1990) 2024 10 212 114337. Qing Zhou, Nong Yang, Mingfang Zhao, Dingzhi Huang, Jun Zhao, Yan Yu, Ying Yuan, Longhua Sun, Xiaorong Dong, Tongmei Zhang, Qian Chu, Xingya Li, Xiangjiao Meng, Huijuan Wang, Xiang Wang, Dongde Wu, Sheng Hu, Jinlu Shan, Lian Liu, Meili Sun, Zhiye Zhang, Haibo Zhu, Jingjing Huang, Mengna Huang, Lingge Cheng, Sujie Zhang, Hui Zhou, Yi-Long |
- Page last reviewed:Feb 1, 2024
- Content source: